TY - JOUR AU - Fair, R. J. AU - Tor, Y. PY - 2014 DA - 2014// TI - Antibiotics and bacterial resistance in the 21st century JO - Perspect Med Chem VL - 6 ID - Fair2014 ER - TY - JOUR AU - Shlaes, D. M. AU - Sahm, D. AU - Opiela, C. AU - Spellberg, B. PY - 2013 DA - 2013// TI - The FDA reboot of antibiotic development JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.01277-13 DO - 10.1128/AAC.01277-13 ID - Shlaes2013 ER - TY - STD TI - Antibiotic resistance threats in the United States (2013) [http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf] UR - http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf ID - ref3 ER - TY - JOUR AU - Sievert, D. M. AU - Ricks, P. AU - Edwards, J. R. AU - Schneider, A. AU - Patel, J. AU - Srinivasan, A. AU - Kallen, A. AU - Limbago, B. AU - Fridkin, S. PY - 2013 DA - 2013// TI - Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010 JO - Infect Control Hosp Epidemiol VL - 34 UR - https://doi.org/10.1086/668770 DO - 10.1086/668770 ID - Sievert2013 ER - TY - JOUR AU - Swenson, B. R. AU - Metzger, R. AU - Hedrick, T. L. AU - McElearney, S. T. AU - Evans, H. L. AU - Smith, R. L. AU - Chong, T. W. AU - Popovsky, K. A. AU - Pruett, T. L. AU - Sawyer, R. G. PY - 2009 DA - 2009// TI - Choosing antibiotics for intra-abdominal infections: what do we mean by “high risk”? JO - Surg Infect (Larchmt) VL - 10 UR - https://doi.org/10.1089/sur.2007.041 DO - 10.1089/sur.2007.041 ID - Swenson2009 ER - TY - JOUR AU - Pitout, J. D. AU - Laupland, K. B. PY - 2008 DA - 2008// TI - Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern JO - Lancet Infect Dis VL - 8 UR - https://doi.org/10.1016/S1473-3099(08)70041-0 DO - 10.1016/S1473-3099(08)70041-0 ID - Pitout2008 ER - TY - JOUR AU - Endimiani, A. AU - Luzzaro, F. AU - Perilli, M. AU - Lombardi, G. AU - Coli, A. AU - Tamborini, A. AU - Amicosante, G. AU - Toniolo, A. PY - 2004 DA - 2004// TI - Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin JO - Clin Infect Dis VL - 38 UR - https://doi.org/10.1086/380645 DO - 10.1086/380645 ID - Endimiani2004 ER - TY - JOUR AU - Kanj, S. S. AU - Kanafani, Z. A. PY - 2011 DA - 2011// TI - Current concepts in antimicrobial therapy against resistant Gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa JO - Mayo Clin Proc VL - 86 UR - https://doi.org/10.4065/mcp.2010.0674 DO - 10.4065/mcp.2010.0674 ID - Kanj2011 ER - TY - JOUR AU - Rodriguez-Bano, J. AU - Navarro, M. D. AU - Romero, L. AU - Muniain, M. A. AU - Cueto, M. AU - Rios, M. J. AU - Hernandez, J. R. AU - Pascual, A. PY - 2006 DA - 2006// TI - Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge JO - Clin Infect Dis VL - 43 UR - https://doi.org/10.1086/508877 DO - 10.1086/508877 ID - Rodriguez-Bano2006 ER - TY - JOUR AU - Solomkin, J. S. AU - Mazuski, J. E. AU - Bradley, J. S. AU - Rodvold, K. A. AU - Goldstein, E. J. AU - Baron, E. J. AU - O’Neill, P. J. AU - Chow, A. W. AU - Dellinger, E. P. AU - Eachempati, S. R. PY - 2010 DA - 2010// TI - Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America JO - Clin Infect Dis VL - 50 UR - https://doi.org/10.1086/649554 DO - 10.1086/649554 ID - Solomkin2010 ER - TY - JOUR AU - Zilberberg, M. D. AU - Shorr, A. F. PY - 2013 DA - 2013// TI - Secular trends in Gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000–2009 JO - Infect Control Hosp Epidemiol VL - 34 UR - https://doi.org/10.1086/671740 DO - 10.1086/671740 ID - Zilberberg2013 ER - TY - JOUR PY - 2013 DA - 2013// TI - Vital signs: carbapenem-resistant Enterobacteriaceae JO - MMWR Morb Mortal Wkly Rep VL - 62 ID - ref12 ER - TY - JOUR AU - Patel, T. S. AU - Nagel, J. L. PY - 2015 DA - 2015// TI - Clinical Outcomes of Enterobacteriaceae Infections Stratified by Carbapenem MICs JO - J Clin Microbiol VL - 53 UR - https://doi.org/10.1128/JCM.03057-14 DO - 10.1128/JCM.03057-14 ID - Patel2015 ER - TY - JOUR AU - Solomkin, J. S. AU - Yellin, A. E. AU - Rotstein, O. D. AU - Christou, N. V. AU - Dellinger, E. P. AU - Tellado, J. M. AU - Malafaia, O. AU - Fernandez, A. AU - Choe, K. A. AU - Carides, A. PY - 2003 DA - 2003// TI - Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial JO - Ann Surg VL - 237 ID - Solomkin2003 ER - TY - JOUR AU - Kollef, M. H. AU - Golan, Y. AU - Micek, S. T. AU - Shorr, A. F. AU - Restrepo, M. I. PY - 2011 DA - 2011// TI - Appraising contemporary strategies to combat multidrug resistant Gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit JO - Clin Infect Dis VL - 53 UR - https://doi.org/10.1093/cid/cir475 DO - 10.1093/cid/cir475 ID - Kollef2011 ER - TY - JOUR AU - Jones, R. N. AU - Huynh, H. K. AU - Biedenbach, D. J. AU - Fritsche, T. R. AU - Sader, H. S. PY - 2004 DA - 2004// TI - Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations JO - J Antimicrob Chemother VL - 54 UR - https://doi.org/10.1093/jac/dkh298 DO - 10.1093/jac/dkh298 ID - Jones2004 ER - TY - JOUR AU - Mushtaq, S. AU - Ge, Y. AU - Livermore, D. M. PY - 2004 DA - 2004// TI - Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential JO - Antimicrob Agents Chemother VL - 48 UR - https://doi.org/10.1128/AAC.48.8.3086-3092.2004 DO - 10.1128/AAC.48.8.3086-3092.2004 ID - Mushtaq2004 ER - TY - JOUR AU - Pankey, G. A. PY - 2005 DA - 2005// TI - Tigecycline JO - J Antimicrob Chemother VL - 56 UR - https://doi.org/10.1093/jac/dki248 DO - 10.1093/jac/dki248 ID - Pankey2005 ER - TY - JOUR AU - Falagas, M. E. AU - Karageorgopoulos, D. E. AU - Dimopoulos, G. PY - 2009 DA - 2009// TI - Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline JO - Curr Drug Metab VL - 10 UR - https://doi.org/10.2174/138920009787048356 DO - 10.2174/138920009787048356 ID - Falagas2009 ER - TY - JOUR AU - Ellis-Grosse, E. J. AU - Babinchak, T. AU - Dartois, N. AU - Rose, G. AU - Loh, E. PY - 2005 DA - 2005// TI - The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam JO - Clin Infect Dis VL - 41 UR - https://doi.org/10.1086/431675 DO - 10.1086/431675 ID - Ellis-Grosse2005 ER - TY - JOUR AU - Cai, Y. AU - Wang, R. AU - Liang, B. AU - Bai, N. AU - Liu, Y. PY - 2011 DA - 2011// TI - Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.01402-10 DO - 10.1128/AAC.01402-10 ID - Cai2011 ER - TY - JOUR AU - Hong, M. C. AU - Hsu, D. I. AU - Bounthavong, M. PY - 2013 DA - 2013// TI - Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and beta-lactamase-inhibitor combination JO - Infec Drug Resistance VL - 6 ID - Hong2013 ER - TY - JOUR AU - Zhanel, G. G. AU - Chung, P. AU - Adam, H. AU - Zelenitsky, S. AU - Denisuik, A. AU - Schweizer, F. AU - Lagace-Wiens, P. R. AU - Rubinstein, E. AU - Gin, A. S. AU - Walkty, A. PY - 2014 DA - 2014// TI - Ceftolozane/tazobactam: a novel cephalosporin/beta-lactamase inhibitor combination with activity against multidrug-resistant Gram-negative bacilli JO - Drugs VL - 74 UR - https://doi.org/10.1007/s40265-013-0168-2 DO - 10.1007/s40265-013-0168-2 ID - Zhanel2014 ER - TY - JOUR AU - Farrell, D. J. AU - Flamm, R. K. AU - Sader, H. S. AU - Jones, R. N. PY - 2013 DA - 2013// TI - Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011–2012) JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.01802-13 DO - 10.1128/AAC.01802-13 ID - Farrell2013 ER - TY - JOUR AU - Livermore, D. M. AU - Mushtaq, S. AU - Warner, M. AU - Zhang, J. AU - Maharjan, S. AU - Doumith, M. AU - Woodford, N. PY - 2011 DA - 2011// TI - Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.00756-10 DO - 10.1128/AAC.00756-10 ID - Livermore2011 ER - TY - JOUR AU - Zhanel, G. G. AU - Lawson, C. D. AU - Adam, H. AU - Schweizer, F. AU - Zelenitsky, S. AU - Lagace-Wiens, P. R. AU - Denisuik, A. AU - Rubinstein, E. AU - Gin, A. S. AU - Hoban, D. J. PY - 2013 DA - 2013// TI - Ceftazidime-avibactam: a novel cephalosporin/beta-lactamase inhibitor combination JO - Drugs VL - 73 UR - https://doi.org/10.1007/s40265-013-0013-7 DO - 10.1007/s40265-013-0013-7 ID - Zhanel2013 ER - TY - JOUR AU - Lucasti, C. AU - Jasovich, A. AU - Umeh, O. AU - Jiang, J. AU - Kaniga, K. AU - Friedland, I. PY - 2008 DA - 2008// TI - Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study JO - Clin Ther VL - 30 UR - https://doi.org/10.1016/j.clinthera.2008.04.019 DO - 10.1016/j.clinthera.2008.04.019 ID - Lucasti2008 ER - TY - JOUR AU - Babinchak, T. AU - Ellis-Grosse, E. AU - Dartois, N. AU - Rose, G. M. AU - Loh, E. PY - 2005 DA - 2005// TI - Tigecycline 301 Study Group, Tigecycline 306 Study Group: The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data JO - Clin Infect Dis VL - 41 UR - https://doi.org/10.1086/431676 DO - 10.1086/431676 ID - Babinchak2005 ER - TY - JOUR AU - Fomin, P. AU - Koalov, S. AU - Cooper, A. AU - Babinchak, T. AU - Dartois, N. AU - Vane, N. AU - Castaing, N. AU - Tellado, J. PY - 2008 DA - 2008// TI - The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections - the European experience JO - J Chemother VL - 20 UR - https://doi.org/10.1179/joc.2008.20.Supplement-1.12 DO - 10.1179/joc.2008.20.Supplement-1.12 ID - Fomin2008 ER - TY - JOUR AU - Oliva, M. E. AU - Rekha, A. AU - Yellin, A. AU - Pasternak, J. AU - Campos, M. AU - Rose, G. M. AU - Babinchak, T. AU - Ellis-Grosse, E. J. AU - Loh, E. PY - 2005 DA - 2005// TI - A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744] JO - BMC Infect Dis VL - 5 UR - https://doi.org/10.1186/1471-2334-5-88 DO - 10.1186/1471-2334-5-88 ID - Oliva2005 ER - TY - JOUR AU - Chen, Z. AU - Wu, J. AU - Zhang, Y. AU - Wei, J. AU - Leng, X. AU - Bi, J. AU - Li, R. AU - Yan, L. AU - Quan, Z. AU - Chen, X. PY - 2010 DA - 2010// TI - Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial JO - BMC Infect Dis VL - 10 UR - https://doi.org/10.1186/1471-2334-10-217 DO - 10.1186/1471-2334-10-217 ID - Chen2010 ER - TY - JOUR AU - Qvist, N. AU - Warren, B. AU - Leister-Tebbe, H. AU - Zito, E. T. AU - Pedersen, R. AU - McGovern, P. C. AU - Babinchak, T. PY - 2012 DA - 2012// TI - Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial JO - Surg Infect (Larchmt) VL - 13 UR - https://doi.org/10.1089/sur.2011.048 DO - 10.1089/sur.2011.048 ID - Qvist2012 ER - TY - JOUR AU - Erasmo, A. A. AU - Crisostomo, A. C. AU - Yan, L. N. AU - Hong, Y. S. AU - Lee, K. U. AU - Lo, C. M. PY - 2004 DA - 2004// TI - Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection JO - Asian J Surg VL - 27 UR - https://doi.org/10.1016/S1015-9584(09)60039-7 DO - 10.1016/S1015-9584(09)60039-7 ID - Erasmo2004 ER - TY - JOUR AU - Malangoni, M. A. AU - Song, J. AU - Herrington, J. AU - Choudhri, S. AU - Pertel, P. PY - 2006 DA - 2006// TI - Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections JO - Ann Surg VL - 244 UR - https://doi.org/10.1097/01.sla.0000230024.84190.a8 DO - 10.1097/01.sla.0000230024.84190.a8 ID - Malangoni2006 ER - TY - JOUR AU - Lucasti, C. AU - Hershberger, E. AU - Miller, B. AU - Yankelev, S. AU - Steenbergen, J. AU - Friedland, I. AU - Solomkin, J. PY - 2014 DA - 2014// TI - Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections JO - Antimicrob Agents Chemother VL - 58 UR - https://doi.org/10.1128/AAC.00049-14 DO - 10.1128/AAC.00049-14 ID - Lucasti2014 ER - TY - STD TI - Eckmann C, Hershberger E, Miller B, Wooley M, Friedland I, Steenbergen J, Collins S, Yuan G, Barie P, Solomkin J: P0266a. Efficacy and safety of ceftolozane/tazobactam versus meropenem in the treatment of complicated intra-abdominal infections (cIAI) in hospitalised adults: results from the phase 3 aspect-cIAI trial. [Abstract] In: 24th Annual European Congress of Clinical Microbiology and Infectious Diseases: May 10–13 2014; Barcelona, Spain; 2014. https://www.escmid.org/escmid_library/online_lecture_library/?search=1¤t_page=1&search_term=Christian+Eckmann Accessed 7/30/201 UR - https://www.escmid.org/escmid_library/online_lecture_library/?search=1¤t_page=1&search_term=Christian+Eckmann ID - ref36 ER - TY - JOUR AU - Lucasti, C. AU - Popescu, I. AU - Ramesh, M. K. AU - Lipka, J. AU - Sable, C. PY - 2013 DA - 2013// TI - Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, phase II trial JO - J Antimicrob Chemother VL - 68 UR - https://doi.org/10.1093/jac/dks523 DO - 10.1093/jac/dks523 ID - Lucasti2013 ER - TY - JOUR AU - Naber, K. G. AU - Llorens, L. AU - Kaniga, K. AU - Kotey, P. AU - Hedrich, D. AU - Redman, R. PY - 2009 DA - 2009// TI - Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis JO - Antimicrob Agents Chemother VL - 53 UR - https://doi.org/10.1128/AAC.00837-08 DO - 10.1128/AAC.00837-08 ID - Naber2009 ER - TY - JOUR AU - Redman, R. AU - Damiao, R. AU - Kotey, P. AU - Kaniga, K. AU - Davies, T. AU - Naber, K. G. PY - 2010 DA - 2010// TI - Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis JO - J Chemother VL - 22 UR - https://doi.org/10.1179/joc.2010.22.6.384 DO - 10.1179/joc.2010.22.6.384 ID - Redman2010 ER - TY - STD TI - Wagenlehner F, Umeh O, Huntington J, Cloutier D, Friedland I, Steenbergen J, Yuan G, Yoon M, Darouiche R: eP449. Efficacy and safety of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (CUTI)/pyelonephritis in hospitalised adults: results from the phase 3 aspect-CUTI trial. [Abstract] In: 24th Annual European Congress of Clinical Microbiology and Infectious Diseases: May 10–13 2014; Barcelona, Spain; 2014. https://www.escmid.org/escmid_library/online_lecture_library/?search=1¤t_page=1&search_term=eP449https://www.escmid.org/escmid_library/online_lecture_library/?search=1¤t_page=1&search_term=eP449. Accessed 7/30/2015 UR - https://www.escmid.org/escmid_library/online_lecture_library/?search=1¤t_page=1&search_term=eP449 ID - ref40 ER - TY - JOUR AU - Vazquez, J. A. AU - Gonzalez Patzan, L. D. AU - Stricklin, D. AU - Duttaroy, D. D. AU - Kreidly, Z. AU - Lipka, J. AU - Sable, C. PY - 2012 DA - 2012// TI - Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study JO - Curr Med Res Opin VL - 28 UR - https://doi.org/10.1185/03007995.2012.748653 DO - 10.1185/03007995.2012.748653 ID - Vazquez2012 ER -